118 related articles for article (PubMed ID: 1382223)
1. Structure-mutagenicity relationships in a series of indolo[3,2-c]quinoline-1,4-diones that have shown cytotoxic properties on leukemia cells.
Min S; Helissey P; Callais F; Giorgi-Renault S; Festy B
Mutat Res; 1992 Oct; 280(4):225-31. PubMed ID: 1382223
[TBL] [Abstract][Full Text] [Related]
2. Structure-mutagenicity relationships in series of 11H-indolo[3,2-c]quinoline-1,4-diones, tetrahydro-11H-indolo[3,2-c]quinoline-1,4-diones and 11H-pyrido[3',4':4,5]pyrrolo[3,2-c]quinoline-1,4-diones with leukemia cytotoxic properties. Relations with topoisomerase I inhibiting properties.
Callais F; Helissey P; Min S; Festy B; Giorgi-Renault S
Mutat Res; 1994 Nov; 311(1):149-56. PubMed ID: 7526168
[TBL] [Abstract][Full Text] [Related]
3. Mutagenicity of quinolines in Salmonella typhimurium TA100. A QSAR study based on hydrophobicity and molecular orbital determinants.
Debnath AK; de Compadre RL; Hansch C
Mutat Res; 1992 Jul; 280(1):55-65. PubMed ID: 1377345
[TBL] [Abstract][Full Text] [Related]
4. Quantitative structure-mutagenic activity relationships of triazino indole derivatives.
García E; Lopez-de-Cerain A; Martinez-Merino V; Monge A
Mutat Res; 1992 Jul; 268(1):1-9. PubMed ID: 1378175
[TBL] [Abstract][Full Text] [Related]
5. Mutagenicity of nitrophenanthrene derivatives for Salmonella typhimurium: effects of nitroreductase and acetyltransferase.
Sera N; Fukuhara K; Miyata N; Tokiwa H
Mutat Res; 1996 Jan; 349(1):137-44. PubMed ID: 8569786
[TBL] [Abstract][Full Text] [Related]
6. Mutagenicity of substituted anthraquinones in the Ames/Salmonella microsome system.
Krivobok S; Seigle-Murandi F; Steiman R; Marzin DR; Betina V
Mutat Res; 1992 May; 279(1):1-8. PubMed ID: 1374527
[TBL] [Abstract][Full Text] [Related]
7. Effect of various alkyl and unsaturated substituents on the mutagenicity of some nitrophenyl thioethers.
Juneja TR; Talukdar A; Mehta N; Gupta RL
Mutat Res; 2001 Aug; 495(1-2):97-102. PubMed ID: 11448647
[TBL] [Abstract][Full Text] [Related]
8. Relationship between mutagenic potency in Salmonella typhimurium and chemical structure of amino- and nitro-substituted biphenyls.
Nohara M; Hirayama T; Fujioka Y; Ozasa S; Ibuki E; Fukui S
Mutat Res; 1985 Mar; 149(1):9-15. PubMed ID: 3883151
[TBL] [Abstract][Full Text] [Related]
9. Anthracene-9,10-diones as potential anticancer agents: bacterial mutation studies of amido-substituted derivatives reveal an unexpected lack of mutagenicity.
Venitt S; Crofton-Sleigh C; Agbandje M; Jenkins TC; Neidle S
J Med Chem; 1998 Sep; 41(19):3748-52. PubMed ID: 9733500
[TBL] [Abstract][Full Text] [Related]
10. Heterocyclic quinones. XVI. Pharmacomodulation in the series of 11H-indolo[3,2-c]quinolinediones: synthesis, cytotoxicity and antitumor activity of 3-substituted 11H-pyrido[3',4':4,5]pyrrolo[3,2-c]quinoline-1,4-diones.
Helissey P; Giorgi-Renault S; Renault J; Cros S
Chem Pharm Bull (Tokyo); 1989 Sep; 37(9):2413-6. PubMed ID: 2557983
[TBL] [Abstract][Full Text] [Related]
11. Caffeine-derived N-nitroso compounds. III: Mutagenicity in S. typhimurium and in vitro induction of DNA single-strand breaks in rat hepatocytes by mononitrosocaffeidine and dinitrosocaffeidine.
Erdinger L; Schmezer P; Razdan R; Kumar R; Spiegelhalder B; Preussmann R; Siddiqi M
Mutat Res; 1993 Aug; 292(1):41-9. PubMed ID: 7688096
[TBL] [Abstract][Full Text] [Related]
12. Isolation and studies of the mutagenic activity in the Ames test of flavonoids naturally occurring in medical herbs.
Czeczot H; Tudek B; Kusztelak J; Szymczyk T; Dobrowolska B; Glinkowska G; Malinowski J; Strzelecka H
Mutat Res; 1990 Mar; 240(3):209-16. PubMed ID: 2179716
[TBL] [Abstract][Full Text] [Related]
13. Mutagenic activity of three synthetic isomers of the food carcinogen 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in the Ames test.
Vikse R; Klungsøyr L; Grivas S
Mutat Res; 1993 Dec; 319(4):273-8. PubMed ID: 7504200
[TBL] [Abstract][Full Text] [Related]
14. The effectiveness of Salmonella strains TA100, TA102 and TA104 for detecting mutagenicity of some aldehydes and peroxides.
Dillon D; Combes R; Zeiger E
Mutagenesis; 1998 Jan; 13(1):19-26. PubMed ID: 9491389
[TBL] [Abstract][Full Text] [Related]
15. Mutagenic activity of newly synthesized sulfa drugs to Salmonella typhimurium.
Temcharoen P; Nerapattanakid S; Toskulkao C; Glinsukon T; Paovaro C; Ruchirawat S
Mutat Res; 1994 Jun; 321(4):187-95. PubMed ID: 7515156
[TBL] [Abstract][Full Text] [Related]
16. Mutagenicity of polycyclic aromatic hydrocarbons and quinones on Salmonella typhimurium TA97.
Sakai M; Yoshida D; Mizusaki S
Mutat Res; 1985; 156(1-2):61-7. PubMed ID: 3889628
[TBL] [Abstract][Full Text] [Related]
17. Microbial mutagenicity of 3- and 4-ring polycyclic aromatic sulfur heterocycles.
Pelroy RA; Stewart DL; Tominaga Y; Iwao M; Castle RN; Lee ML
Mutat Res; 1983 Apr; 117(1-2):31-40. PubMed ID: 6188045
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationships of a series of antitumoral 5,8-quinazolinediones in mutagenicity studies.
Callais F; Min S; Giorgi-Renault S; Festy B
Mutat Res; 1991 Sep; 261(1):51-6. PubMed ID: 1715513
[TBL] [Abstract][Full Text] [Related]
19. Salmonella/human S9 mutagenicity test: a collaborative study with 58 compounds.
Hakura A; Shimada H; Nakajima M; Sui H; Kitamoto S; Suzuki S; Satoh T
Mutagenesis; 2005 May; 20(3):217-28. PubMed ID: 15843387
[TBL] [Abstract][Full Text] [Related]
20. Mutagenicity of alkylhydrazine oxalates in Salmonella typhimurium TA100 and TA102 demonstrated by modifying the growth conditions of the bacteria.
Matsushita H; Endo O; Matsushita H; Yamamoto M; Mochizuki M
Mutat Res; 1993 Apr; 301(4):213-22. PubMed ID: 7680754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
